EU seeks answers from AstraZeneca on cut to vaccine supplies
AstraZeneca, which developed its shot with Oxford University, told the EU on Friday that it could not meet the agreed supply targets running up to the end of March, with an EU official telling Reuters that meant a 60% cut to 31 million doses
Mon, 25 Jan, 2021